| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |